Concepts (192)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ear, Inner | 7 | 2025 | 12 | 2.250 |
Why?
|
| Endoscopy | 5 | 2021 | 92 | 1.750 |
Why?
|
| Cochlea | 4 | 2018 | 17 | 1.570 |
Why?
|
| Hearing Loss, Sensorineural | 3 | 2023 | 35 | 1.490 |
Why?
|
| Genetic Therapy | 3 | 2026 | 852 | 1.200 |
Why?
|
| Meniere Disease | 3 | 2026 | 8 | 1.140 |
Why?
|
| Round Window, Ear | 1 | 2025 | 1 | 0.930 |
Why?
|
| Temporal Bone | 4 | 2025 | 11 | 0.900 |
Why?
|
| Drug Delivery Systems | 4 | 2025 | 333 | 0.900 |
Why?
|
| Hair Cells, Auditory | 4 | 2025 | 15 | 0.870 |
Why?
|
| SOXB1 Transcription Factors | 3 | 2025 | 23 | 0.710 |
Why?
|
| Neural Stem Cells | 2 | 2020 | 47 | 0.640 |
Why?
|
| Hearing Loss, Central | 1 | 2020 | 2 | 0.640 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 26 | 0.630 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 20 | 0.630 |
Why?
|
| Speech | 1 | 2020 | 64 | 0.610 |
Why?
|
| Speech Perception | 1 | 2020 | 80 | 0.580 |
Why?
|
| Receptor, trkB | 1 | 2018 | 7 | 0.550 |
Why?
|
| Diphosphonates | 1 | 2018 | 33 | 0.540 |
Why?
|
| Hearing Loss | 2 | 2018 | 55 | 0.530 |
Why?
|
| Spiral Ganglion | 4 | 2023 | 6 | 0.530 |
Why?
|
| Neuroprotective Agents | 1 | 2018 | 80 | 0.520 |
Why?
|
| Neuroma, Acoustic | 1 | 2017 | 8 | 0.510 |
Why?
|
| Nasal Surgical Procedures | 1 | 2016 | 2 | 0.500 |
Why?
|
| Nasal Obstruction | 1 | 2016 | 4 | 0.500 |
Why?
|
| Stem Cells | 2 | 2016 | 278 | 0.490 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2016 | 34 | 0.480 |
Why?
|
| Health Personnel | 1 | 2020 | 391 | 0.470 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2016 | 61 | 0.450 |
Why?
|
| Pandemics | 1 | 2020 | 691 | 0.450 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 318 | 0.440 |
Why?
|
| Membrane Glycoproteins | 1 | 2018 | 667 | 0.430 |
Why?
|
| Regeneration | 2 | 2026 | 127 | 0.370 |
Why?
|
| Hair Cells, Auditory, Inner | 2 | 2023 | 4 | 0.370 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2025 | 1663 | 0.350 |
Why?
|
| Otologic Surgical Procedures | 2 | 2021 | 8 | 0.340 |
Why?
|
| Stria Vascularis | 2 | 2026 | 2 | 0.330 |
Why?
|
| Animals | 14 | 2026 | 21493 | 0.300 |
Why?
|
| Humans | 20 | 2026 | 65845 | 0.290 |
Why?
|
| Cell Differentiation | 3 | 2025 | 1391 | 0.240 |
Why?
|
| Cochlear Nerve | 2 | 2018 | 4 | 0.240 |
Why?
|
| Mice | 9 | 2025 | 11185 | 0.220 |
Why?
|
| Cholesteatoma, Middle Ear | 2 | 2021 | 6 | 0.220 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2025 | 663 | 0.220 |
Why?
|
| Pharmaceutical Preparations | 2 | 2023 | 126 | 0.210 |
Why?
|
| Pneumocephalus | 1 | 2023 | 5 | 0.200 |
Why?
|
| Drugs, Investigational | 1 | 2023 | 12 | 0.200 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2025 | 312 | 0.190 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2025 | 229 | 0.190 |
Why?
|
| Aphasia | 1 | 2023 | 48 | 0.190 |
Why?
|
| Child, Preschool | 2 | 2025 | 2090 | 0.180 |
Why?
|
| Infant, Newborn | 1 | 2025 | 1439 | 0.170 |
Why?
|
| Infant | 1 | 2025 | 1718 | 0.160 |
Why?
|
| Analgesics | 1 | 2020 | 102 | 0.150 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2021 | 128 | 0.150 |
Why?
|
| Neuroglia | 1 | 2020 | 81 | 0.150 |
Why?
|
| Endolymphatic Sac | 1 | 2019 | 1 | 0.150 |
Why?
|
| Vestibular Aqueduct | 1 | 2019 | 2 | 0.150 |
Why?
|
| Cadaver | 2 | 2018 | 135 | 0.150 |
Why?
|
| Equipment Design | 1 | 2020 | 374 | 0.140 |
Why?
|
| Vestibular Nerve | 1 | 2018 | 1 | 0.140 |
Why?
|
| Denervation | 1 | 2018 | 18 | 0.140 |
Why?
|
| Cells, Cultured | 4 | 2016 | 2194 | 0.140 |
Why?
|
| Chorea | 2 | 2008 | 10 | 0.140 |
Why?
|
| Neurites | 1 | 2018 | 23 | 0.140 |
Why?
|
| Child | 2 | 2025 | 4653 | 0.140 |
Why?
|
| Glucose Transporter Type 1 | 2 | 2008 | 52 | 0.130 |
Why?
|
| Adolescent | 3 | 2025 | 6368 | 0.130 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2018 | 39 | 0.130 |
Why?
|
| Genome | 2 | 2017 | 286 | 0.130 |
Why?
|
| Molecular Docking Simulation | 1 | 2018 | 81 | 0.130 |
Why?
|
| Neurogenesis | 1 | 2018 | 64 | 0.130 |
Why?
|
| Labyrinth Diseases | 1 | 2016 | 1 | 0.130 |
Why?
|
| Decision Trees | 1 | 2016 | 48 | 0.120 |
Why?
|
| Neurons | 2 | 2020 | 935 | 0.120 |
Why?
|
| Anatomic Landmarks | 1 | 2016 | 6 | 0.120 |
Why?
|
| Pilot Projects | 2 | 2018 | 1030 | 0.120 |
Why?
|
| Drug Design | 1 | 2016 | 139 | 0.120 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2016 | 76 | 0.120 |
Why?
|
| Male | 6 | 2025 | 31410 | 0.110 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2016 | 119 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 2 | 2017 | 690 | 0.110 |
Why?
|
| Cochlear Nucleus | 1 | 2014 | 1 | 0.110 |
Why?
|
| Auditory Pathways | 1 | 2014 | 7 | 0.110 |
Why?
|
| Female | 6 | 2025 | 34425 | 0.110 |
Why?
|
| Optogenetics | 1 | 2014 | 31 | 0.110 |
Why?
|
| Patient Selection | 1 | 2017 | 484 | 0.110 |
Why?
|
| Cohort Studies | 2 | 2020 | 2651 | 0.100 |
Why?
|
| Atlases as Topic | 1 | 2014 | 14 | 0.100 |
Why?
|
| Patient Compliance | 1 | 2016 | 370 | 0.100 |
Why?
|
| HEK293 Cells | 1 | 2016 | 617 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 799 | 0.100 |
Why?
|
| Molecular Sequence Annotation | 1 | 2014 | 67 | 0.100 |
Why?
|
| Osteoprotegerin | 1 | 2013 | 6 | 0.100 |
Why?
|
| Vestibulocochlear Nerve Diseases | 1 | 2013 | 2 | 0.100 |
Why?
|
| Retrospective Studies | 1 | 2025 | 6957 | 0.100 |
Why?
|
| Prospective Studies | 1 | 2020 | 3340 | 0.090 |
Why?
|
| Nerve Degeneration | 1 | 2013 | 68 | 0.090 |
Why?
|
| Wnt3A Protein | 1 | 2012 | 3 | 0.090 |
Why?
|
| Cholera | 1 | 2012 | 16 | 0.090 |
Why?
|
| Organ of Corti | 1 | 2011 | 3 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2012 | 141 | 0.080 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2011 | 83 | 0.080 |
Why?
|
| Transcriptome | 1 | 2014 | 408 | 0.080 |
Why?
|
| Anemia, Hemolytic | 1 | 2008 | 13 | 0.070 |
Why?
|
| Glucose | 2 | 2008 | 478 | 0.070 |
Why?
|
| Cations | 1 | 2008 | 64 | 0.070 |
Why?
|
| Epilepsy | 1 | 2008 | 113 | 0.060 |
Why?
|
| Transcription, Genetic | 2 | 2025 | 911 | 0.060 |
Why?
|
| Adult | 4 | 2019 | 17579 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2025 | 2168 | 0.050 |
Why?
|
| Mice, Inbred CBA | 2 | 2014 | 80 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 2 | 2014 | 372 | 0.040 |
Why?
|
| Ear Canal | 1 | 2021 | 4 | 0.040 |
Why?
|
| Ear, Middle | 1 | 2021 | 7 | 0.040 |
Why?
|
| Animals, Newborn | 2 | 2012 | 241 | 0.040 |
Why?
|
| Tympanic Membrane Perforation | 1 | 2020 | 3 | 0.040 |
Why?
|
| Mutation | 1 | 2008 | 2675 | 0.040 |
Why?
|
| Aging | 2 | 2019 | 784 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2020 | 344 | 0.040 |
Why?
|
| Autopsy | 1 | 2019 | 56 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 1635 | 0.040 |
Why?
|
| Fetus | 1 | 2019 | 103 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2014 | 1583 | 0.030 |
Why?
|
| Patents as Topic | 1 | 2016 | 6 | 0.030 |
Why?
|
| Phenotype | 2 | 2013 | 1236 | 0.030 |
Why?
|
| Tinnitus | 1 | 2016 | 17 | 0.030 |
Why?
|
| Species Specificity | 1 | 2017 | 344 | 0.030 |
Why?
|
| Inferior Colliculi | 1 | 2014 | 1 | 0.030 |
Why?
|
| Channelrhodopsins | 1 | 2014 | 3 | 0.030 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2014 | 15 | 0.030 |
Why?
|
| Auditory Cortex | 1 | 2014 | 12 | 0.030 |
Why?
|
| Acoustic Stimulation | 1 | 2014 | 62 | 0.030 |
Why?
|
| Photic Stimulation | 1 | 2014 | 89 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2013 | 3506 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 2014 | 139 | 0.030 |
Why?
|
| Action Potentials | 1 | 2014 | 113 | 0.030 |
Why?
|
| Genes, Essential | 1 | 2014 | 20 | 0.030 |
Why?
|
| Transcription Initiation Site | 1 | 2014 | 47 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2014 | 84 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2014 | 173 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2014 | 201 | 0.020 |
Why?
|
| Plastic Embedding | 1 | 2013 | 1 | 0.020 |
Why?
|
| Schwann Cells | 1 | 2013 | 9 | 0.020 |
Why?
|
| Paraffin Embedding | 1 | 2013 | 18 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2014 | 267 | 0.020 |
Why?
|
| Time Factors | 1 | 2020 | 3779 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2013 | 213 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 160 | 0.020 |
Why?
|
| Thermolysin | 1 | 2012 | 1 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 2790 | 0.020 |
Why?
|
| Thrombospondins | 1 | 2012 | 6 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2012 | 44 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2014 | 593 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 449 | 0.020 |
Why?
|
| Pregnancy | 1 | 2019 | 2401 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2012 | 105 | 0.020 |
Why?
|
| Wnt Signaling Pathway | 1 | 2012 | 87 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2012 | 491 | 0.020 |
Why?
|
| Cell Survival | 1 | 2013 | 588 | 0.020 |
Why?
|
| Myosins | 1 | 2012 | 118 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 899 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2013 | 323 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2011 | 185 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2012 | 664 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 243 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2020 | 5834 | 0.020 |
Why?
|
| Cell Line | 1 | 2014 | 2031 | 0.020 |
Why?
|
| Quality of Life | 1 | 2016 | 1266 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 5682 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2012 | 1292 | 0.020 |
Why?
|
| Lod Score | 1 | 2008 | 23 | 0.020 |
Why?
|
| Xenopus | 1 | 2008 | 55 | 0.020 |
Why?
|
| Physical Exertion | 1 | 2008 | 81 | 0.020 |
Why?
|
| Pedigree | 1 | 2008 | 193 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 198 | 0.020 |
Why?
|
| Apoptosis | 1 | 2013 | 1100 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2008 | 156 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2008 | 147 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 297 | 0.020 |
Why?
|
| Middle Aged | 2 | 2019 | 18501 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2008 | 233 | 0.020 |
Why?
|
| Proteins | 1 | 2012 | 764 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2014 | 1561 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2008 | 502 | 0.010 |
Why?
|
| Biomarkers | 1 | 2011 | 1503 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 1590 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 1980 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 1193 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 15147 | 0.010 |
Why?
|
| Exercise | 1 | 2008 | 970 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2008 | 2324 | 0.010 |
Why?
|